Cargando…

Why does Leigh syndrome respond to immunotherapy?

Detalles Bibliográficos
Autores principales:	Finsterer, Josef, Zarrouk-Mahjoub, Sinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470935/ https://www.ncbi.nlm.nih.gov/pubmed/28649511 http://dx.doi.org/10.1016/j.ymgmr.2016.07.008

Ejemplares similares

Vaccination triggering onset of m.8993T > G associated Leigh syndrome
por: Finsterer, Josef, et al.
Publicado: (2018)

Transient symmetric T2-hyperintensities of basal ganglia and brainstem not only point to Leigh syndrome
por: Finsterer, Josef, et al.
Publicado: (2016)

Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG
por: Finsterer, Josef, et al.
Publicado: (2017)

Response to letter to the editor: Why does Leigh syndrome responds to immunotherapy?
por: Chuquilin, Miguel, et al.
Publicado: (2016)

Arrhythmias in MELAS syndrome
por: Finsterer, Josef, et al.
Publicado: (2016)

Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders
por: Finsterer, Josef, et al.
Publicado: (2017)

Stroke in MELAS is a Vasogenic Edema and not Ischemic
por: Finsterer, Josef, et al.
Publicado: (2020)

MELAS syndrome due to the m.3291T > C mutation
por: Finsterer, Josef, et al.
Publicado: (2016)

Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016)

Diagnosis of Kearns-Sayre Syndrome Requires Comprehensive Work-up
por: Finsterer, Josef, et al.
Publicado: (2016)

Diagnose Kearns–Sayre syndrome genetically and investigate the phenotype comprehensively
por: Finsterer, Josef, et al.
Publicado: (2016)

Nephrocalcinosis and retinal dystrophy, rare manifestations of MPV17-related mitochondrial depletion syndrome?()
por: Finsterer, Josef, et al.
Publicado: (2016)

Is chronic fatigue syndrome truly associated with haplogroups or mtDNA single nucleotide polymorphisms?
por: Finsterer, Josef, et al.
Publicado: (2016)

Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene()
por: Finsterer, Josef, et al.
Publicado: (2017)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
por: Finsterer, Josef, et al.
Publicado: (2016)

Double trouble progressive external ophthalmoplegia and Huntington's disease()
por: Finsterer, Josef, et al.
Publicado: (2016)

Phenotypic heterogeneity of a compound heterozygous SUCLA2 mutation()()()
por: Finsterer, Josef, et al.
Publicado: (2016)

Phenotypic heterogeneity of MELAS()()
por: Finsterer, Josef, et al.
Publicado: (2016)

Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016)

Comment on “A Rare Case of Renal Infarct due to Noncompaction Cardiomyopathy: A Case Report and Literature Review”
por: Finsterer, Josef, et al.
Publicado: (2016)

Specification of the Myopathy Type may Influence the Management of Noncompaction
por: Finsterer, Josef, et al.
Publicado: (2016)

Leber’s hereditary optic neuropathy is multiorgan not mono-organ
por: Finsterer, Josef, et al.
Publicado: (2016)

Mitochondrial vasculopathy due to the m.3243A > G mutation is not restricted to the carotid artery
por: Finsterer, Josef, et al.
Publicado: (2016)

Onset of MELAS due to the m.3243A > G mutation is early if the large phenotypic variability is considered()()
por: Finsterer, Josef, et al.
Publicado: (2016)

Uniform criteria for diagnosing noncompaction by cMRI and echocardiography are warranted
por: Finsterer, Josef, et al.
Publicado: (2016)

Assessment of the phenotype genotype variability and correlation in m.3243A > G mutation carriers requires prospective studies
por: Finsterer, Josef, et al.
Publicado: (2016)

Unusual recovery of respiratory chain complex-III deficiency upon G-tube feeding and a cocktail
por: Finsterer, Josef, et al.
Publicado: (2016)

Non-compaction is not a simple genetic disorder
por: Finsterer, Josef, et al.
Publicado: (2014)

Acquired non-compaction in integrin-myopathy
por: Finsterer, Josef, et al.
Publicado: (2013)

Impaired Hearing in Mitochondrial Disorders
por: Finsterer, Josef, et al.
Publicado: (2015)

Low blood heteroplasmy-rate may cause late-onset MELAS()()()
por: Finsterer, Josef, et al.
Publicado: (2017)

ND2 mutation with minimal coenzyme-Q responsive manifestations()
por: Finsterer, Josef, et al.
Publicado: (2017)

Clozapine for mitochondrial psychosis()
por: Finsterer, Josef, et al.
Publicado: (2017)

Gastrointestinal Involvement in m.3243A>G-associated MELAS
por: Finsterer, Josef, et al.
Publicado: (2017)

Biomarkers for Detecting Mitochondrial Disorders
por: Finsterer, Josef, et al.
Publicado: (2018)

Comment on “Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis”
por: Finsterer, Josef, et al.
Publicado: (2018)

Phenotypic Heterogeneity of the m.14459G>A Mutation
por: Finsterer, Josef, et al.
Publicado: (2017)

Heteroplasmy of the m.3243A>G Mutation May Influence Phenotypic Heterogeneity
por: Finsterer, Josef, et al.
Publicado: (2017)

Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
por: Finsterer, Josef, et al.
Publicado: (2017)

Involvement of the Spinal Cord in Mitochondrial Disorders
por: Finsterer, Josef, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vn1rk2v89b70fn05imgif9hpg5